Company / Assets per Share
Kiniksa Pharmaceuticals International, plc Assets per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$10.62
FY2025
5-year range
$4.31 / $10.62
FY2021-FY2025
Trend
+28.8%
vs FY2024
Sector context
#93 of 210
Health Care
What the data says
At $10.62, Kiniksa Pharmaceuticals International, plc's assets per share ranks #93 of 210 in the Health Care sector. Assets per Share has increased for 4 consecutive years, from $4.31 in FY2021 to $10.62 in FY2025.
Based on SEC 10-K filings.
10.62 in FY2025 with a 5-year CAGR of +13.4%.
Improved from $7.67 to $10.62 over the past 2 years.
Health Care sector context is included.
Assets per Share over time
Growth rates
- 3-Year CAGR
- +12.6%
- 5-Year CAGR
- +13.4%
- 10-Year CAGR
- -
Sector benchmark
#93 of 210 in Health CareTop 44% of 210This company $10.62 Sector average $296.79
▼
-96.4% below sector average
Key checks
Key Insights
- Kiniksa Pharmaceuticals International, plc's assets per share has grown for 4 consecutive years.
- In FY2025, assets per share increased 28.8% year-over-year.
- Ranks #93 out of 210 companies in the Health Care sector.
- Peak assets per share was recorded in FY2017.
Company context
Key Data Points
- Negative profit margin: -10.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $10.62 | +28.8% |
| FY2024 | $8.24 | +7.4% |
| FY2023 | $7.67 | +3.3% |
| FY2022 | $7.43 | +72.6% |
| FY2021 | $4.31 | -23.8% |
| FY2020 | $5.65 | +20.0% |
| FY2019 | $4.71 | -56.8% |
| FY2018 | $10.90 | -58.5% |
| FY2017 | $26.24 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026